Construction and characterization of mutants in the neurofibromatosis type 2 tumor suppressor gene
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF NEUROMEDICINE
- Issue:
- 12
- DOI:
- 10.3760/cma.j.issn.1671-8925.2009.12.001
- Key Word:
- 定点突变;真核表达载体;Ⅱ型神经纤维瘤;抑癌基因;神经鞘瘤细胞;Site-directed mutagenesis;Eukaryotic expression vector;Neurofibromatosis type 2;Tumor suppressor gene;Rat schwannoma cell
Abstract： Objective To construct the eukaryotic expression vector of mutants in the neurofibromatosis type 2 (NF2) tumor suppressor gene and observe its expression in rat schwannoma cell line RT4. Methods Site-directed mutagenesis was performed to induce the mutation of the codons for the residue Ile 546 in pEGFP-N1-NF2 into Met to construct the muton of pEGFP-N1-NF2~(△Ⅱe546Met). After lipofectin-mediated transient transformation of RT4 with the plasmids containing the mutation and the one without mutation, respectively, the mRNA and protein expression levels of NF2 were determined using fluorescence imaging and Western blotting. The cell proliferation was determined by the MTT assay. Results DNA sequence analysis confirmed the success of site-directed mutagenesis and Western blotting showed that pEGFP-NF2 protein could be expressed in the RT4 cells. The RT4 cell inhibition rate in the pEGFP-N1-NF2~(△Ⅱe546Met) transfection group was statistically lower than that in the pEGFP-N1-NF2 transfected group (P<0.05).Conclusion The recombinant plasmids pEGFP-N1-NF2~(△Ⅱe546Met) has been successfully constructed with efficient expressions in RT4.
- [1]卞留贯,孙青芳,沈建康,等.神经鞘瘤的NF2基因2、4、6、13外显子突变分析[J].2001,(6).
- [2]贺子建,王晓强,卞留贯,等.NF2基因及其蛋白merlin的生物学研究进展[J].2006,(2).
- [3]贺子建,卞留贯,贺华,等.野生型Ⅱ型神经纤维瘤病基因Ⅱ亚型真核表达载体的构建及其功能[J].2007,(4).
- [4]沈建康,卞留贯,孙青芳,等.神经鞘瘤的NF2基因突变分析[J].2002,(2).
- [5]Tsukita S,Shimizu T,Seto A,etc.Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.[J].2002,277(12).
- [6]Huson SM,Shenton A,Evans DG,etc.What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?[J].2008,108(1).
- [7]MacCollin M,Ratner N,Nakai Y,etc.Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells.[J].2006,26(13).
- [8]Andrea I. McClatchey,J. Guillermo Paez,Reuben J. Shaw,etc.The Nf2 Tumor Suppressor, Merlin, Functions in Rac-Dependent Signaling[J].2001,1(1).
- [9]Hanemann CO,Hanenberg H,Schulze-KM M,etc.Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis.[J].2002,11(1).
- [10]Christopher S, Eddleman,James K, Liu.Optic nerve sheath meningioma: current diagnosis and treatment.[J].2007,23(5).
- [11]Schefler AC,Berrocal AM,Dubovy SR.Optical coherence tomography characteristics of epiretinal membranes in neurofibromatosis 2.[J].2008,39(1).
- [12]Lev MH,Slattery-WH 3rd,Doherty JK,etc.Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.[J].2007,28(8).
- [13]Genuardi M,Bacci C,Sestini R,etc.Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.[J].2008,29(2).
- [14]Lee B. Jacoby,Deborah Jones,Kevin Davis,etc.Molecular Analysis of the NF2 Tumor-Suppressor Gene in Schwannomatosis[J].1997,61(6).